Advanced search
Publication Cover
Leukemia & Lymphoma Volume 62, 2021 - Issue 6
Submit an article Journal homepage
155
Views
3
CrossRef citations to date
0
Altmetric
Letters to the Editor

Level of evidence for FDA drug approvals in pivotal clinical trials of hematological malignancies

Samer Al HadidiDepartment of Hematology and Oncology, The Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children’s Hospital and Houston Methodist Hospital, Houston, TX, USACorrespondence[email protected]
View further author information
&
Carlos Almeida RamosDepartment of Hematology and Oncology, The Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children’s Hospital and Houston Methodist Hospital, Houston, TX, USAView further author information
Pages 1522-1524 | Received 09 Dec 2020, Accepted 11 Jan 2021, Published online: 24 Jan 2021

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Marc Sorigue & Outi Kuittinen. (2021) Robustness and pragmatism of the evidence supporting the European Society for Medical Oncology guidelines for the diagnosis, treatment, and follow-up of follicular lymphoma. Expert Review of Hematology 14:7, pages 655-668.
Read now

Articles from other publishers (2)

A. Haslam, T. Olivier & V. Prasad. (2023) Design, power, and alpha levels in randomized phase II oncology trials. ESMO Open 8:1, pages 100779.
Crossref
William Wesson, Vincent L. Galate, Douglas W. Sborov, Brian McClune, Aaron M. Goodman, Bishal Gyawali, Vinay Prasad, Saqib Abbasi & Ghulam Rehman Mohyuddin. (2022) Characteristics of clinical trials for haematological malignancies from 2015 to 2020: A systematic review. European Journal of Cancer 167, pages 152-160.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.